PMN up 15.5% on Nov 3 2026 with no filing that explains it
PMN+15.5%on Tue Nov 3 2026
ProMIS Neurosciences Inc. Common Shares (ON) was up 15.5% on the day at $3.47, ranked #63 on 20.9× its usual five-minute volume, when TapeRank recorded this unexplained move at 12:36 ET during regular hours.
THE DAY ON THE LIST · 1 EVENT
- 12:36 ETUNEXPLAINED MOVE · REGULAR
$3.47 · ▲ 15.5% ON THE DAY · 20.9× 5M RVOL · RANK #63
UNEXPLAINEDCONFIDENCE5/5PMN is up 16.7% with a sharp volume surge, but the supplied material contains no concrete operating or corporate catalyst. The analyst note is a rating and valuation update rather than a substantive company event, so order flow is driving the move.
WHYA 16.7% move on 21.5x normal volume is much larger than the significance of an analyst-maintenance note with a reduced valuation estimate.ANALYZED 12:38 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 12:36 ET
LAST3.47DAY▲ 15.5%5 MIN▲ 0.31%5M RVOL20.9×5M $VOL$175KFLOAT*9.0MRANK#63SESSIONREGULARVWAP3.38HOD3.56LOD3.05OR HIGH3.44OR LOW3.28PREV CLOSE3.00PM HIGH3.44PM LOW3.05GAP▲ 9.67%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $3.29, +9.7% on the previous close of $3.00
- 09:30 ETRegular-session low, $3.28
- 15:43 ETRegular-session high, $3.62
- 15:59 ETLast trade of the regular session, $3.34, +11.3% on the previous close of $3.00
- Volume: 894K shares in regular hours, 74K before the open
PMN opened at $3.29 after closing at $3.00, briefly dipped to $3.28, and climbed through the session to reach $3.62 at 15:43 ET before easing to $3.34 at the regular-session close. TapeRank recorded an unexplained move at 12:36 ET and read it as unexplained, noting that the available material contained no concrete operating or corporate catalyst; the Roth Capital item was an analyst rating and valuation update, not a substantive company event. The stock finished the regular session 11.3% above the previous close, with no halts.
WRITTEN TUE NOV 3 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 08:28 ET4 — PRIMARY DOCUMENTSEC 4
- 08:26 ET4 — PRIMARY DOCUMENTSEC 4
- MON 13:03 ETRoth Capital Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $15Benzinga
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list